William Michael Barr, MD in Clarksdale, MS - Medicare

William Michael Barr, MD is a medicare enrolled "General Practice" physician in Clarksdale, Mississippi. His current practice location is 1800 Cheryl Street, Clarksdale, Mississippi. You can reach out to his office (for appointments etc.) via phone at (662) 624-8511.

William Michael Barr is licensed to practice in Mississippi (license number 10848) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1811061450.

Contact Information

	William Michael Barr, MD
	1800 Cheryl Street, Clarksdale, MS 38614
	(662) 624-8511
	(662) 627-1002

Physician's Profile

Full Name	William Michael Barr
Gender	Male
Speciality
Experience	Years
Location	1800 Cheryl Street, Clarksdale, Mississippi
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

William Michael Barr attended and graduated from in

NPI Data:

NPI Number: 1811061450
Provider Enumeration Date: 11/17/2006
Last Update Date: 06/12/2023

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for William Michael Barr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811061450	NPI	-	NPPES
00013461	Medicaid	MS
110901001	Medicaid	AR
2L0374	Other	MS	MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	10848 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Michael Barr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Michael Barr, MD 1800 Cheryl St, Clarksdale, MS 38614-7219 Ph: (662) 483-1488	William Michael Barr, MD 1800 Cheryl Street, Clarksdale, MS 38614 Ph: (662) 624-8511

News Archive

Discussions in progress for implementing Medisafe 1 Technology's device in Israel Blood Banks

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today a significant progress on the discussions to implement the company's safety pre-matching locking device technology for blood transfusion vials with Israel's national Emergency Medical Services Provider who oversee the entire Nation's Blood Banks.

Newly published manuscripts enhance understanding of the immune system

MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas - chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE).

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

William Michael Barr, MD - Medicare in Clarksdale, MS